These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 7240824)

  • 1. [A study on the significance of bromocriptine (CB-154) administration in normoprolactinemic anovulatory women (author's transl)].
    Ishimaru T; Mori H; Koh K; Imamichi S; Morisaki M; Kohno A; Yoshida K; Imamura S; Yamabe T
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 Oct; 32(10):1583-90. PubMed ID: 7240824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Study on hyperprolactinemic anovulatory syndrome and treatment with bromocriptine (author's transl)].
    Fukunaga T
    Acta Obstet Gynaecol Jpn; 1981 Feb; 33(2):229-38. PubMed ID: 7015779
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The ovulation-inducing effect of CB-154 on normoprolactinemic anovulatory subjects (author's transl)].
    Tamura T; Minakami H
    Nihon Naibunpi Gakkai Zasshi; 1982 Jan; 58(1):49-62. PubMed ID: 6802683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation of LH and prolactin pulses in normoprolactinemic women with ovulatory disturbances and variation of LH and FSH pulses and secreting capacity by administration of bromocriptine in the same cases].
    Kato K; Watanabe R; Ito E; Sakamoto T; Morishima M; Hoshino K; Tanaka M; Tadokoro N
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2241-50. PubMed ID: 3100705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of bromocriptine on FSH and LH secretion in women with euprolactinemic anovulation (author's transl)].
    Mori H; Aisaka K; Kigawa T; Minakuchi H; Sakamoto S
    Nihon Sanka Fujinka Gakkai Zasshi; 1981 Oct; 33(10):1741-8. PubMed ID: 6796631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Serum prolactin levels during sleep and in metoclopramide stimulation in normoprolactinemic anovulation and ovulation induction with bromocriptine].
    Suginami H; Ito T; Hamada K; Yano K; Matsuura S
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 May; 38(5):728-34. PubMed ID: 3722953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovulation induction with bromocriptine in normoprolactinemic anovulatory women.
    Suginami H; Hamada K; Yano K; Kuroda G; Matsuura S
    J Clin Endocrinol Metab; 1986 May; 62(5):899-903. PubMed ID: 3958126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The effects of bromocriptine on anovulatory patients with high LH and euprolactinemia].
    Mori H; Aisaka K; Matsuoka R; Kigawa T
    Nihon Naibunpi Gakkai Zasshi; 1985 Jan; 61(1):48-55. PubMed ID: 3922814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bromocriptine response in normoprolactinemic patients with polycystic ovary disease: a preliminary report.
    Seibel MM; Oskowitz S; Kamrava M; Taymor ML
    Obstet Gynecol; 1984 Aug; 64(2):213-9. PubMed ID: 6234484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between pituitary reserve and efficacy of bromocriptine in women with euprolactinemic ovulatory dysfunction.
    Lin KC
    Gaoxiong Yi Xue Ke Xue Za Zhi; 1994 May; 10(5):222-8. PubMed ID: 8040924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperprolactinemic amenorrhea. Clinical relevance, endocrine features, therapy (author's transl)].
    Rjosk HK; Werder K; Fahlbusch R
    Geburtshilfe Frauenheilkd; 1976 Jul; 36(7):575-87. PubMed ID: 986336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unusual prolactin response to luteinizing hormone-releasing hormone in some anovulatory women.
    Giampietro O; Moggi G; Chisci R; Coluccia A; Luche AD; Simonini N; Brunori I
    J Clin Endocrinol Metab; 1979 Jul; 49(1):141-3. PubMed ID: 376544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exaggerated prolactin response of thyrotropin-releasing hormone in women with anovulatory cycles: possible role of endogenous estrogens and effect of bromocriptine.
    Peillon F; Vincens M; Cesselin F; Doumith R; Mowszowicz I
    Fertil Steril; 1982 Apr; 37(4):530-5. PubMed ID: 6802681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolactin response to thyrotropin-releasing hormone in normoprolactinemic patients with ovulatory dysfunction and its use for selection of candidates for bromocriptine therapy.
    Steinberger E; Nader S; Rodriguez-Rigau L; Ayala C; Smith K
    J Endocrinol Invest; 1990 Sep; 13(8):637-42. PubMed ID: 2148756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The combined effect of bromocriptine and clomiphene citrate on normoprolactinemic anovulation; the lack of effectiveness of clomiphene citrate treatment alone].
    Kubota T; Kamata S; Ohhara M; Koyama T; Nishi N; Saito M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Dec; 38(12):2223-30. PubMed ID: 3805832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Failure of bromocriptine to restore the menstrual cycle in normoprolactinemic post-pill amenorrhea.
    Coelingh Bennink HJ; van der Steeg HJ
    Fertil Steril; 1983 Feb; 39(2):238-40. PubMed ID: 6822306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined therapy of bromocriptine, clomiphene citrate and HMG in normoprolactinemic amenorrhea patients who fail to respond to bromocriptine-clomiphene citrate therapy].
    Kubota T; Ohhara M; Nishi N; Saito M; Kamata S; Yaoi Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1987 Mar; 39(3):455-62. PubMed ID: 3104513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of hydergine in hyperprolactinemia.
    Tamura T; Satoh T; Minakami H; Tamada T
    J Clin Endocrinol Metab; 1989 Aug; 69(2):470-4. PubMed ID: 2753986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with bromocriptine and clomiphene citrate for patients with normoprolactinemic amenorrhea.
    Kubota T; Kamada S; Aso T
    Int J Fertil; 1992; 37(5):277-82. PubMed ID: 1358838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.